Population-based colorectal cancer (CRC) screening using fecal occult blood tests has shown to be effective in reducing the high burden of worldwide CRC-related mortality [1] . Fecal immunochemical tests (FIT) are replacing the former guaiac fecal occult blood (gFOBT) test as primary screening method because of their higher sensitivity, quantitative nature, and higher participation rates [2, 3] . Compared to gFOBT, FIT is easier to use as it is a one-sample test and does not require dietary restrictions [3] . Yet, FIT is not a highly accurate test. Depending on the positivity cutoff used, no advanced neoplasia (AN) is detected at colonoscopy in 45-70% of FIT-positive participants [4] [5] [6] . Furthermore, up to 10% of participants with a negative FIT appear to have CRC or one of its precursor lesions [4, 7] .
MethodS
The review is described in accordance with the PRISMA guidelines (Supplementary table 1) [15] . The protocol of this study was not included in an accessible registry. This review addressed the question: do participants in population-screening with a specific participant-related factor more often have a false-positive/falsenegative FIT result compared to participants without that risk factor. We planned to select the risk factors as reported in the individual studies.
Search strategy and eligibility criteria
Databases Pubmed, Embase, and Cochrane were searched (29 January 2017) with the assistance of a specialized librarian, using MeSH terms and text words for colorectal cancer, screening, fecal immunochemical test, false-positivity, false-negativity, sensitivity, and specificity (Supplementary table 2) .
Two reviewers (LV and CK) independently selected potentially eligible full-text articles from the search results by scanning title and abstract of all identified records. Reference lists of selected articles and reviews were scanned for other relevant publications. Any disagreement was solved through discussion. Potentially eligible articles were read in full-text to make final decisions about inclusion.
Eligible studies had assessed risk factors for false-positive/ false-negative FIT results, defined as the presence or absence of AN (advanced adenoma and/or CRC) at colonoscopy; in a population-based screening program, a pilot program, or in a similar research setting. These inclusion criteria were chosen to minimize the chance of missing articles that reported false results as secondary outcome. Excluded were studies only described in conference abstracts, letters to the editor, or in articles without quantitative results on the association of risk factors with false FIT results, which would preclude the calculation of relative risks. Also excluded were studies not available in full-text report after contacting the corresponding author.
Since we aimed at personal factors known at time of screening, we also excluded studies assessing the effect of changing positivity cutoffs only, the effect of number of FITs performed in one screening round, the effect of sample return period or season, and studies assessing risk factors found at colonoscopy.
Data extraction
Two authors (LV and CK) independently reviewed included articles and extracted relevant data using a standardized extraction form. Data were collected on publication year, study setting, data collection period, number of included patients, type of FIT used, FIT cutoff value for positivity, definition of a false FIT result (detection/no detection of AN), evaluated risk factors and total numbers of positive FIT results, total number of participants with and without risk factors and total of participants with and without AN at colonoscopy. Positivity cutoff values were reported in µg hemoglobin (Hb)/g feces and, where needed, converted from ng Hb/ml buffer [16] .
Risk of bias assessment
The risk of bias of included studies was assessed using the QUIPS tool for prognostic reviews [17] . QUIPS includes the domains 'prognostic factor measurement' and 'outcome measurement' , which were considered more appropriate to assess risk of bias of studies on risk factors than the comparable domains in QUADAS 'index test' and 'reference test' [18] . The other evaluated QUIPS domains were participation, study attrition, study confounding and statistical analysis and reporting. Risk of bias on each domain was graded as low, intermediate or high, following the recommendations of the Cochrane Prognosis Methods Group.
Data analysis and synthesis
To allow for meta-analysis, relative risks for reported risk factors were recalculated with the data in the study report. From 2 × 2 contingency tables, risk ratios for false-positive FIT results were calculated by dividing the proportion of false-positive results, relative to all FIT-positives, in the group with the risk factor by the proportion of false-positive results, relative to all FIT-positives, in the group without that risk factor. Similarly, false-negative relative risks were calculated using the false-negative proportions in each group.
For each risk factor, we calculated a summary estimate of the relative risk in meta-analysis, whenever this factor had been included in at least two study reports. We used Mantel-Haenszel's randomeffects method, and calculated 95% confidence intervals to assess statistically significance, relying on a predefined significance level of p < 0.05 [19] . Forest plots were composed for each meta-analysis. Heterogeneity was assessed with I 2 statistics [20] . An I 2 of <25% was considered low, 25-50% moderate, and >50% high heterogeneity. Funnel plots were screened to assess publication bias. We used Review Manager version 5.3.5 (The Nordic Cochrane
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Centre, Copenhagen) for statistical (meta-)analyses. For reporting, risk factors are grouped into the broader categories demographic factors, medication use, medical history/comorbidities. A sensitivity analysis was performed with studies using the same positivity cutoff level of 20 µg Hb/g feces.
reSultS
Study selection
The search strategy yielded 518 records ( Fig. 1) . We removed 109 duplicates, 354 records based on title and abstract, 13 conference abstracts, 1 letter, 3 abstracts without full text, 7 articles without relevant results [21] [22] [23] [24] [25] [26] [27] , 10 articles only evaluating risk factors found at colonoscopy [4, [28] [29] [30] [31] [32] [33] or organizational aspects [34] [35] [36] , and 7 articles that reported insufficient data to calculate risk ratios [12, 13, [37] [38] [39] [40] [41] . This resulted in 14 articles included for review ( Table 1 ) [14, [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] .
Study characteristics
Included studies and their characteristics are summarized in Table 1 . All data had been collected within an existing or pilot screening program with a cohort design, except for one study [14] that was part of a randomized controlled trial comparing FIT with colonoscopy screening. OC-Sensor was the most frequently used FIT brand. Positivity cutoffs varied between studies and between FIT brand (2 µg Hb/g feces to 50 μg Hb/g feces). The most fre-quently used cutoff, in six studies, was 20 μg Hb/g feces. Diagnostic accuracy of FIT was calculated based on the detection of AN in all studies except two that additionally included intermediate-risk adenomas [43, 44] .
Risk of bias across studies
Risk of bias evaluations for each study are shown in Supplementary figure 1. A high risk of bias for outcome measurement was assigned to five studies because of an undefined FIT brand or cutoff level for positivity, but overall risk of bias was considered limited. The risk of bias assessment did not lead to any exclusion of or correction in studies.
Risk factors for false-positive results
Risk factors and their association with false-positive FIT results in each study are described in Table 2a and summary results are presented in Table 3 (forest plots in Supplementary figures 2a-2l) . The most frequently studied risk factors for false-positive results are the use of anticoagulants and antithrombotic drugs (10 results: [14, 44, 47, 51, 54] ), sex (5 results: [44, 46, 49, 50, 53] ), and age (5 results: [44] [45] [46] 53] ).
The risk factor that was associated with a lower risk of false-positive results in meta-analysis was male sex (RR 0.84, CI 0.74-0.94, I 2 84%), and, in one study, elevated triglycerides (RR 0.85, CI 0.76-0.96) and age higher than 65 (RR 0.77, CI 0.65-0.92). In contrast, a higher risk of false-positive results was seen in participants using No significant associations were found for having hemorrhoids (RR 0.99, CI 0.93-1.97, I 2 93%, or the use of anticoagulants or antithrombotic drugs (RR 1.01, CI 0.96-1.06, I 2 0%). Only one study [47] reported a significantly lower risk of false-positivity when using low dose of aspirin (RR 0.46, CI 0.24-0.86), while in another study [46] the use of aspirin (or aspirin in combination with NSAIDs) was associated with a significantly higher risk of a false-positive result (RR 1.16, CI 1.05-1.28). Many other factors appeared to have no systematic effect on the proportion of false-positive results: family history of CRC, socioeconomic status, obesity, diverticula, high blood pressure, hyperglycemia, low highdensity lipoprotein (HDL), metabolic syndrome, menstruation or menopause, anemia, use of a selective serotonin reuptake inhibitor (SSRI) or use of (combined) medication, (a history of) smoking or drinking alcohol and participating in prior screening rounds.
Risk Factors for False-Negative Results
Risk factors for false-negative FIT results as evaluated in each study are summarized in Table 2b and summary results are presented in No association with false-negative results was found for (known) diverticulosis, other elements of metabolic syndrome, NSAID or aspirin use, prior screening, or a previous CRC.
Sensitivity Analysis of Studies Using an Equal Positivity Cutoff
A sensitivity analysis of the six studies that used a positivity cutoff of 20 μg Hb/gr feces [42-44, 48, 51, 53] , did not change the main conclusions. However, the analysis of NSAID use as risk factor was limited to one study, not showing a higher risk of a false-positive result (RR 1.18, CI 0.90-1.55). Similarly, hyperglycemia (RR 1.25, CI 0.94-1.67) and hypertension (RR 1.30, CI 0.98-1.74) did not lead to a higher risk of a false-negative result. Some associations could not be evaluated because no studies with a 20 µg Hb/gr feces positivity cutoff included them: higher age and (a history of) drinking alcohol.
dIScuSSIon
This systematic review shows that male sex is associated with a significantly lower risk of false-positive FIT results, while using NSAIDs is associated with a higher risk of a false-positive result. The use of anticoagulants has been studied frequently, but no systematic effect on FIT false-positivity was observed. Males, participants with a family history of CRC, with elements of the metabolic syndrome (obesity, hyperglycemia, hypertension), and (former) smokers were found to be at increased risk of false-negative results.
When interpreting this review several limitations should be acknowledged. First, data on FIT accuracy were compiled from different (pilot) screening programs, using different FIT brands and unequal cutoffs for positivity. Applying a higher cutoff level will lower sensitivity while increasing specificity, thus influencing the proportion of false-negative and false-positive screenees. However, since we compared the risks of any false result per study (proportion of participants with the risk factor vs. the proportion without that risk factor), differences in cutoff levels between studies should have little impact on the conclusions, as was shown in a sensitivity analysis of six studies using the same cutoff. Seven studies that reported insufficient data (absolute numbers) to allow for relative risk calculation were excluded, limiting the precision of summary estimates. To allow for meta-analysis, individual risk factors were clustered in groups, leading to possible loss of detail in characterizing risk factors. For example, all types of anticoagulant and antithrombotic drugs had to be clustered. Lastly, reporting bias is possible with regard to the prevalence of hemorrhoids, since these lesions are frequently not included in systematic colonoscopy reporting systems.
Differences between subgroups in the risk of a false-negative FIT result and in the risk of a false-positive FIT result could be due to differences in prevalence, differences in accuracy, or a combination. A higher CRC prevalence in one subgroup will result in a higher risk of a false-negative result and a lower risk of a falsepositive result, even in the absence of a difference in accuracy. A lower FIT sensitivity in a subgroup will generate more falsenegatives, and a lower specificity will generate more false-positives (see supplementary material for a worked-out example). Due to the nature of the studies included in this review, we cannot distinguish between these causes as explanations for differences in the risk of false-negatives and false-positives. 
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Men are at lower risk of false-positive results and at higher risk of false-negative results. In single studies, similar conclusions have been drawn for participants at a higher age. This is likely related to the higher prevalence of CRC and AN in men and older individuals [55, 56] , and raises the question whether the screening strategy should be optimized per subgroup. For men and older participants, the cutoff could be lowered to decrease the number of missed AN. Furthermore, the cutoff could be increased for women and younger participants to decrease the number of unnecessary colonoscopies in these populations. The most important question is the consequence of these modifications for the specificity of FIT in men and the sensitivity of FIT in women. Grobbee et al. assessed this balance and concluded that, for both sexes, a decrease in cutoff resulted in a relatively more rapid increase in sensitivity than the decline in specificity [57] . Alvarez et al. found similar results for men over 60 years old. In women younger than 60 years, a higher cutoff led to a significantly lower number of colonoscopies without modifying the detection rate of CRC [23] . Other than adjusting the cutoff for FIT-positivity, effectiveness by gender and age may be improved by adjusting the starting age of screening. Brenner et al. found that women reached equivalent levels of CRC risk as men when they are 4-8 years older, which might justify a postponed screening age for women [58] . Overall, this may support initiatives exploring the specific effect in specific screening populations of a lower cutoff for (older) men, a higher cutoff for (younger) women, or a postponed start of screening in women.
Currently, several research groups are investigating individual risk stratification for colonoscopy screening or colonoscopy referral after a positive FIT result. Among those are the Asia-Pacific Colorectal Screening (APCS) score and the Dutch risk stratification model of Stegeman et al. [59, 60] . Both models include age, family history for CRC and smoking for risk assessment, and APCS additionally includes sex. In our analysis, the same personal factors appeared to be prone for false-negative FIT results, which further supports the use of these factors in risk-based strategies. Possibly, hyperglycemia, obesity and hypertension could additionally be explored for inclusion in colonoscopy referral stratification models in FIT-based screening, since these factors are found to be related to more falsenegative results, and are so far only partially explained by a concomitant higher incidence of AN [61, 62] . The influence of combinations of risk factors could be of interest when these are likely to interact, such as aspects of metabolic syndrome, lifestyle and the use of medication. Because of the way they were reported in the study reports, the effect of combined risk factors could not be assessed in this review, but future original studies provide this opportunity.
Although meta-analysis showed no significant increased risk of a false-positive FIT result for invitees with hemorrhoids, this risk is commonly believed by patients, and was demonstrated in individual studies [42, 44] . An assumed higher chance of false-positive results could restrain this group from participation in follow-up colonoscopy when receiving a positive FIT result. GPs could play a role in informing this specific group. Especially because, in contrast with risk factors such as male sex and higher age, the incidence of AN in this subgroup is similar to those without hemorrhoids.
In line with the European Screening recommendation that anticoagulant drug restrictions in FIT screening are not indicated [3] , we showed that the use of aspirin or anticoagulant drugs does not increase FIT false-positivity in nine out of ten included studies. This may seem counter intuitive. One explanation could be that the absence of an effect is a consequence of both an increased and decreased risk of false-positive results. Anticoagulants could increase positivity and decrease false-positivity if AN is present but bleeds very little by itself. In contrast, anticoagulants could also increase false-positivity if other non-AN lesions are present and bleeding is provoked. Alternative explanations could point to molecular characteristics of AN and the exact mechanism of the anticoagulant used. For current practice, however, recent guidelines are adequate.
This study focused on personal risk factors and its influence on false FIT results. Other factors affecting FIT accuracy should also be acknowledged. Organizational aspects influencing FIT accuracy may for example include sample return times [34] [35] [36] , season of return [34] or number of samples [33, 63] . Further, the colonic lesion itself may relate to the accuracy of FIT. For example, right-sided AN is associated with more false-negative FIT results than proximal lesions [33, 42, 64] . This is thought to be due to the degradation of hemoglobin during colon transit, the blood distribution through the stool [64] , and a harder consistency of passing stool in the distal colon [65] . Similarly, the morphology of the lesion may relate to the (location specific) accuracy of FIT. FIT is less sensitive for the detection of sessile adenomas than for pedunculated adenomas [29, 32] , and proximal adenomas are proportionately more often sessile than distal adenoma [66] . The relevance of studying other than personal factors should however be kept in mind, risks for a false FIT result evaluated during colonoscopy have limited value if risk-based stratification for colonoscopy is intended.
In theory, if advanced adenomas are missed with FIT in a first round but detected in a following round before their progression to CRC, the effectiveness of the screening program is not affected, in contrast to interval cancer. The limited evidence on personal risk factors for FIT interval is conflicting. Higher interval cancer rates were found for women in a gFOBT screening program [67] [68] [69] , but no significant differences for sex or age were found in other studies [70] [71] [72] .
Multiple personal risk factors, known at time of FIT invitation, could influence the proportion of false FIT results in CRC screening. Personalized screening strategies might increase the sensitivity of FIT and reduce the number of unnecessary colonoscopies.
